Back
Guinness Atkinson Asia Pacific Divi Builder ETF Vs. Insmed, Inc. Industry Stock Comparison
Sell
46
ADIV
Guinness Atkinson Asia Pacific Divi Builder ETF
Last Price:
$17.84
Seasonality Move:
-1.87%
Sell
40
INSM
Insmed, Inc.
Last Price:
$174.52
Seasonality Move:
7.61%
Sell
46
Guinness Atkinson Asia Pacific Divi Builder ETF (ADIV)
is a Sell
Is Guinness Atkinson Asia Pacific Divi Builder ETF a Buy, Sell or Hold?
-
The current Guinness Atkinson Asia Pacific Divi Builder ETF [ADIV] share price is $18.00. The Score for ADIV is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ADIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy, Sell or Hold?
-
The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADIV Stock Price Chart
What is Guinness Atkinson Asia Pacific Divi Builder ETF's stock price today?
-
The Guinness Atkinson Asia Pacific Divi Builder ETF share price today is $18.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADIV is experiencing selling pressure, which indicates risk of future bearish movement.
INSM Stock Price Chart
What is Insmed, Inc.'s stock price today?
-
The Insmed, Inc. share price today is $166.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.
ADIV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 42.78 | Sell |
| Chaikin Money Flow: | -4412 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.07 - 18.51) | Sell |
| Bollinger Bands (100): | (18 - 18.5) | Sell |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 29.93 | Sell |
| Chaikin Money Flow: | -270452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.54 - 208.08) | Sell |
| Bollinger Bands (100): | (130.7 - 191.18) | Buy |
ADIV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.07 | Sell |
| 20-day SMA: | 18.25 | Sell |
| 50-day SMA: | 18.28 | Sell |
| 200-day SMA: | 17.31 | Buy |
| 8-day EMA: | 18.05 | Sell |
| 20-day EMA: | 18.19 | Sell |
| 50-day EMA: | 18.25 | Sell |
| 200-day EMA: | 17.48 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 192.36 | Sell |
| 20-day SMA: | 199.79 | Sell |
| 50-day SMA: | 186.64 | Sell |
| 200-day SMA: | 121.17 | Buy |
| 8-day EMA: | 191.25 | Sell |
| 20-day EMA: | 194.86 | Sell |
| 50-day EMA: | 184.92 | Sell |
| 200-day EMA: | 135.61 | Buy |
Guinness Atkinson Asia Pacific Divi Builder ETF Earnings Growth & ADIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Insmed, Inc. Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $2.60 per share.
Guinness Atkinson Asia Pacific Divi Builder ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||